Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.40
Bid: 162.00
Ask: 168.60
Change: 0.00 (0.00%)
Spread: 6.60 (4.074%)
Open: 162.40
High: 162.40
Low: 162.40
Prev. Close: 162.40
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

24 May 2018 07:00

RNS Number : 0930P
Sabre Insurance Group PLC
24 May 2018
 

24 May 2018

 

SABRE INSURANCE GROUP PLC

Trading Update

Sabre Insurance Group plc (the "Group", or "Sabre"), one of the UK's leading private motor insurance underwriters, today publishes a trading update ahead of its AGM to be held later this morning.

Summary

· As set out in our 2017 full year results, in common with the rest of the motor market, we experienced competitive pricing in the last few weeks of 2017 which continued into the first two months of 2018 resulting in a modest reduction in premium income relative to the same period in 2017

 

· Pricing action was taken in early March to reflect the improving claims trends, specifically lower whiplash claims frequency, which has resulted in gross written premium ("GWP") returning to approximately 2017 levels on a weekly run-rate basis with no deterioration in our expected underwriting margins. Given this GWP for the year to 30 April 2018 is down year on year by around 5% at £69.8m(1) (2017: £73.1m(1))

 

· The Group continues to deliver leading underwriting performance supported by positive claims experience in the early months of 2018, and therefore reiterates the full year guidance for the 2018 underwriting performance reflecting a combined ratio slightly better than our long-term target of mid-70%'s

 

· A solvency ratio of over 188%(1) at the end of March exceeds our 140% - 160% target corridor, with organic capital being generated on a monthly basis

Geoff Carter, CEO, commented:

"Profitability of business written remains our key priority, with gross written premium and growth being an output rather than a target. Whilst we saw a reduction in premium income in the first two months of the year relative to the equivalent period last year, we took pricing action in early March which was supported by the emerging claims data. Following this action, volumes of new business on a weekly run-rate basis have returned to similar levels as the equivalent period in 2017 without any deterioration in expected underwriting margins. As such we remain confident in performing slightly better than our mid-70%'s combined ratio target for 2018, given our claims experience to date.

The motor market remains in a choppy state as competitors react to the early signs of changing claims patterns. Much uncertainty remains on the end state of these changes, not least around the critical Ogden discount rate which may impact overall claim costs and reinsurance pricing, making it difficult to predict the outcome for pricing and volumes for the remainder of the year and beyond. However, the market appears to have reacted rationally to reflect real-world changes in the cost of claims. Since we undertook our pricing action earlier this year we have seen no significant change in the pricing environment in our sector and, as such, currently expect our 2018 GWP position to be broadly in line with 2017. Assuming no changes to the current environment, we would expect modest GWP growth in 2019, without deterioration from our current underwriting margins.

In summary, we are encouraged by the start to the year. We remain absolutely committed to our core principle of underwriting discipline over GWP growth. We believe this will deliver a strong underwriting performance, and allow us to continue strengthening our capital position which will support the delivery of an attractive dividend, in line with our policy (stated at the time of the IPO) of paying out surplus capital by way of ordinary and special dividends."

(1) Numerical information not subject to audit

Media enquiries

Tulchan Communications LLP

James Macey White, Roger Tejwani & David Ison

020 7353 4200

sabre@tulchangroup.com

Investor enquiries

Sabre Insurance Group plc

Geoff Carter & Adam Westwood

0330 024 4696

adam.westwood@sabre.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEDFMDFASEFI
Date   Source Headline
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change
11th Aug 202310:07 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report 2023
25th Jul 20238:53 amRNSDirector Declaration
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
13th Jun 202310:09 amRNSDirector/PDMR Shareholding
2nd Jun 20233:02 pmRNSDirector/PDMR Shareholding
25th May 202311:22 amRNSResult of AGM
25th May 20239:27 amRNSDirector/PDMR Shareholding
25th May 20237:01 amRNSBoard Appointment
25th May 20237:00 amRNSTrading Update
11th May 202311:42 amRNSDirector/PDMR Shareholding
18th Apr 20233:19 pmRNSDirector/PDMR Shareholding
12th Apr 202311:53 amRNSDirector/PDMR Shareholding
6th Apr 202312:28 pmRNSDirector/PDMR Shareholding
31st Mar 20233:43 pmRNSNotice of AGM
31st Mar 20233:37 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
13th Mar 202312:13 pmRNSDirector/PDMR Shareholding
13th Feb 20231:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.